These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9026748)

  • 21. [A role of growth factors in development of various histological types of uterine leiomyoma].
    Kogan EA; Ignatova VE; Rukhadze TN; Kudrina EA; Ishchenko AI
    Arkh Patol; 2005; 67(3):34-8. PubMed ID: 16075611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous leiomyomatosis of the uterus.
    Bodner K; Bodner-Adler B; Wierrani F; Mayerhofer K; Grünberger W
    Anticancer Res; 2002; 22(3):1881-3. PubMed ID: 12168887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between serum epidermal growth factor and uterine leiomyoma].
    Li M; Li B; Niu Z
    Zhonghua Fu Chan Ke Za Zhi; 2000 Mar; 35(3):175-7. PubMed ID: 11775900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth.
    Wolańska M; Bańkowski E
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):238-44. PubMed ID: 16564125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term treatment of uterine fibromyomas with danazol.
    De Leo V; la Marca A; Morgante G
    Gynecol Obstet Invest; 1999; 47(4):258-62. PubMed ID: 10352389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern.
    Di Lieto A; De Falco M; Mansueto G; De Rosa G; Pollio F; Staibano S
    Steroids; 2005 Feb; 70(2):95-102. PubMed ID: 15631865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical management of fibroids.
    Sankaran S; Manyonda IT
    Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated level of plasma vascular endothelial growth factor after gonadotropin-releasing hormone agonist treatment for leiomyomata.
    Takeda T; Osuga K; Miyake A; Wakabayashi A; Morishige K; Kimura T
    Gynecol Endocrinol; 2008 Dec; 24(12):724-6. PubMed ID: 19172544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium.
    Gentry CC; Okolo SO; Fong LF; Crow JC; Maclean AB; Perrett CW
    Clin Sci (Lond); 2001 Dec; 101(6):691-5. PubMed ID: 11724658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
    van de Ven J; Sprong M; Donker GH; Thijssen JH; Mak-Kregar S; Blankenstein MA
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aromatase and leiomyoma of the uterus.
    Shozu M; Murakami K; Inoue M
    Semin Reprod Med; 2004 Feb; 22(1):51-60. PubMed ID: 15083381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smooth muscle neoplasms of the uterus.
    Tiltman AJ
    Curr Opin Obstet Gynecol; 1997 Feb; 9(1):48-51. PubMed ID: 9090482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of progesterone on growth factor expression in human uterine leiomyoma.
    Maruo T; Matsuo H; Shimomura Y; Kurachi O; Gao Z; Nakago S; Yamada T; Chen W; Wang J
    Steroids; 2003 Nov; 68(10-13):817-24. PubMed ID: 14667973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
    Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
    Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current and Emerging Medical Treatments for Uterine Fibroids.
    Chwalisz K; Taylor H
    Semin Reprod Med; 2017 Nov; 35(6):510-522. PubMed ID: 29100239
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of mifepristone on estrogen and progestin receptors in human uterine leiomyoma].
    Wang H; Jin J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):79-81. PubMed ID: 11809103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An accumulation of insulin-like growth factor I (IGF-I) in human myometrium and uterine leiomyomas in various stages of tumour growth.
    Wolańska M; Bańkowski E
    Eur Cytokine Netw; 2004; 15(4):359-63. PubMed ID: 15627646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroids: pathophysiology and current medical treatment.
    Nowak RA
    Baillieres Best Pract Res Clin Obstet Gynaecol; 1999 Jun; 13(2):223-38. PubMed ID: 10755039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progestins and uterine leiomyoma.
    Schweppe KW
    Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():21-4. PubMed ID: 12227898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.